In drug development, the term Trojan horse encompasses a variety of strategies to deliver drugs in a concealed, safe and efficient way to the target. The main objectives of this strategy are firstly to overcome barriers, such as the blood brain-barrier or simply the cell membrane, which shield the target (Troy) from a drug (the Greeks), secondly, to specifically attack the disease rather than the whole body and thirdly, to achieve a slow drug release over time with no sudden concentration peaks. This approach does not only sound awesome on a metaphoric level, but also makes use of some nifty biological tricks.